Hemera Pharma Alternatives & Competitors
12 companies similar to Hemera Pharma — A University of Verona and Milan spin-offs specialized in regenerative medicine...
Companies similar to Hemera Pharma
BioTissue SA
Pioneers of Tissue Engineering and Regenerative Medicine
Switzerland
Novoron Bioscience
Pioneering lipoprotein-receptor drug development to repair damage and degeneration to the...
San Diego, United States
Q Therapeutics
Q has developed a human cell based therapeutic product to treat degenerative disorders of...
Salt Lake City, United St...
Oligogen, Inc.
Oligogen, Inc. is a biotech startup developing stem cell therapies for central nervous sys...
Japan
Rival Readout
Competing with Hemera Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
EG 427
French biotech EG 427 pioneers pinpoint gene therapy using Herpes Simplex Virus 1 for chro...
Apic Bio
Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Anti...
BioAxone Therapeutic, Inc.
Pioneering neuroscience solutions with breakthrough therapies for neurological disorders,...
Aspect Biosystems
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusi...
Canada
StemSight - Vision Unlimited
Curing blindness with regenerative cell therapies.
Tampere, Finland
AgeX Therapeutics, Inc.
AgeX Therapeutics is focused on the development and commercialization of novel therapeutic...
Alameda, United States
Orthocell Ltd
Orthocell (ASX:OCC) is a regenerative medicine company empowering the body to heal | Tag o...
Australia
MICA Biosystems
An innovative and dynamic biotech start-up, unlocking the potential of stem cells and nano...
London, United Kingdom
About Hemera Pharma
Hemera Pharma is a biotechnology startup founded in 2021 as a spin-off of the University of Verona and the University of Milan. The company specializes in regenerative medicine for neurological diseases, focusing on the development of cellular therapy for the regeneration of damaged nerve tissues. Their groundbreaking...
Regenerative Medicine, Neurological Diseases, Cell Therapy, Spinal Cord Injury, Central Nervous System Disorders, Advanced Therapy, Regeneration Of Nervous Tissue, Orphan Diseases
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Hemera Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Hemera Pharma on 13 Sep 2024. The 12 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
